期刊
ADVANCED SCIENCE
卷 9, 期 24, 页码 -出版社
WILEY
DOI: 10.1002/advs.202104594
关键词
desmoplasia; molecular targeting; nanomedicine; pancreatic cancer; photodynamic therapy
资金
- National Institutes of Health [K99CA215301, R00CA215301, P01CA084203, R01CA156177, R01CA160998, S10OD012326]
- Bullock-Wellman Fellowship
- Science Foundation Ireland [IvP 13/IA/1894]
- Irish Research Council [GOIPG/2016/1250]
- Irish Research Council (IRC) [GOIPG/2016/1250] Funding Source: Irish Research Council (IRC)
Desmoplasia, a characteristic of pancreatic ductal adenocarcinoma (PDAC), poses barriers to treatment and affects patient outcomes. This study demonstrates a novel targeted liposomal therapy that combines photodynamic and chemotherapeutic effects while also remediating desmoplasia. The results show significant inhibition of tumor growth and improved survival, highlighting the potential of this therapy in extending the lives of PDAC patients.
Desmoplasia is characteristic of pancreatic ductal adenocarcinoma (PDAC), which exhibits 5-year survival rates of 3%. Desmoplasia presents physical and biochemical barriers that contribute to treatment resistance, yet depleting the stroma alone is unsuccessful and even detrimental to patient outcomes. This study is the first demonstration of targeted photoactivable multi-inhibitor liposomes (TPMILs) that induce both photodynamic and chemotherapeutic tumor insult, while simultaneously remediating desmoplasia in orthotopic PDAC. TPMILs targeted with cetuximab (anti-EGFR mAb) contain lipidated benzoporphyrin derivative (BPD-PC) photosensitizer and irinotecan. The desmoplastic tumors comprise human PDAC cells and patient-derived cancer-associated fibroblasts. Upon photoactivation, the TPMILs induce 90% tumor growth inhibition at only 8.1% of the patient equivalent dose of nanoliposomal irinotecan (nal-IRI). Without EGFR targeting, PMIL photoactivation is ineffective. TPMIL photoactivation is also sixfold more effective at inhibiting tumor growth than a cocktail of Visudyne-photodynamic therapy (PDT) and nal-IRI, and also doubles survival and extends progression-free survival by greater than fivefold. Second harmonic generation imaging reveals that TPMIL photoactivation reduces collagen density by >90% and increases collagen nonalignment by >10(3)-fold. Collagen nonalignment correlates with a reduction in tumor burden and survival. This single-construct phototoxic, chemotherapeutic, and desmoplasia-remediating regimen offers unprecedented opportunities to substantially extend survival in patients with otherwise dismal prognoses.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据